RYBREVANT
Live / Registered — Registered (as of 20 Jul 2021)
What this means for you
Registered since 20 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87876593
- Registration number
- 6428623
- Mark type
- Stylized text
- Filed
- 13 Apr 2018
- Published for opposition
- 10 Jul 2018
- Registered
- 20 Jul 2021
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of oncologic diseases
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 24 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Jun 2021 — USE AMENDMENT FILED
- 07 Jun 2021 — TEAS STATEMENT OF USE RECEIVED
- 12 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2021 — SOU EXTENSION 5 GRANTED
- 18 Feb 2021 — SOU EXTENSION 5 FILED
- 09 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Feb 2021 — SOU TEAS EXTENSION RECEIVED
- 18 Feb 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED